Moreover, as shown in Fig. 6c–h, immunohistochemical examination demonstrated that BMSC-EVs significantly reduced the infiltration of F4/80+ macrophages (P < 0.001) and CD4+/CD8+ lymphocytes (P < 0.001), and both were significantly increased in BLM-treated SSc mice. This evidence concerns the gene CD4 and systemic sclerosis.